Epilepsy :: Lamictal effective in treating patients with partial seizures

Data from two clinical trials presented at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended re-lease formulation of Lamictal? (lamotrigine) is effective as add-on treatment in patients with partial epilepsy with and without secondary generalization. Lamictal XR Extended-Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, new generation epilepsy treatment taken once-daily.

Epilepsy :: Young epileptic children could benefit from animal model of epilepsy

Researchers have developed an animal model of infantile spasms, improving the likelihood of finding new treatments for the thousands of young children who suffer from these catastrophic epilepsy seizures, according to research to be presented at the American Academy of Neurology?s 59th Annual Meeting in Boston, April 28 ? May 5, 2007.